New Atlas Reveals Glioma’s Hidden Complexity

Researchers have created the most detailed spatial multiomic atlas to date of glioma tumour microenvironments, shedding new light on why these aggressive brain cancers are so difficult to treat. By combining spatial proteomics, transcriptomics and glycomics, the team analysed 670 tumour lesions from 310 adult and paediatric patients, generating a rich, open-source dataset for the cancer research community.

Gliomas are among the deadliest cancers, with survival often measured in months for the most aggressive forms such as glioblastoma (GBM). The new study helps explain why: tumour cells within the same lesion can vary dramatically in their expression of so-called “targetable” antigens.

Why Targeted Therapies Fail

Single-cell analyses revealed that even widely studied targets such as B7H3 and EGFR are inconsistently expressed. While GBM and pleomorphic xanthoastrocytoma showed a high prevalence of B7H3-positive tumour cells, most gliomas – including many childhood tumours – expressed candidate tumour antigens in fewer than half of their cancer cells.

This variability means that therapies designed to attack a single antigen may leave large portions of the tumour untouched, allowing cancer cells to survive and regrow. The findings provide a biological explanation for why promising immunotherapy and targeted therapy trials have often failed to deliver lasting benefits.

The study also examined paired samples from patients with isocitrate dehydrogenase (IDH)-mutant gliomas, comparing tumours before and after recurrence. Rather than being driven solely by genetic changes in cancer cells, recurrence was linked to a profound spatial reorganisation of the tumour microenvironment.

Immune Signals Predict Survival

In initial tumours, immune niches rich in T cells and vasculature-associated myeloid cells were common. At recurrence, these niches gave way to tumours dominated by microglia and CD206-positive macrophages, suggesting that immune remodelling plays a central role in disease progression and treatment resistance.

By integrating multiple data layers, the researchers identified N-glycosylation patterns as the strongest classifier of tumour grade. Meanwhile, immune-related gene expression programmes emerged as the most powerful predictor of survival in glioblastoma, outperforming traditional clinical and molecular markers.

Beyond its scientific findings, the atlas is being released as a community resource, offering a baseline map of glioma tumour microenvironments across all stages of disease. Researchers say it provides a new framework for glioma classification, outcome prediction and the rational design of future therapies that account for the full complexity of glioma biology.

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  

https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    

https://kneereplacement-stickclub.blogspot.com. for info on knee replacement

https://GSiyers home remedies.blogspot.com   is the latest addition to my blogs

 

Common Anti-Diarrhea Drug Found to Kill Brain Cancer Cells

Sometimes, finding a treatment for previously incurable health conditions doesn’t require the invention of new medications at all. There are those rare cases when existing medications are found to be effective in treating other seemingly unrelated conditions. This is exactly what had happened in the case of loperamide, better known under its commercial name Imodium, a common diarrhea medication.

According to a German research group from the Institute of Experimental Cancer Research in Paediatrics at Goethe University, this affordable and widely-accessible drug can kill the cells of glioblastoma tumors, the most aggressive type of brain cancer.

According to Mayo Clinic, glioblastoma is “an aggressive type of cancer that can occur in the brain or spinal cord. Glioblastoma forms from cells called astrocytes that support nerve cells”. Although glioblastoma can occur at any age, it is more widespread in older adults, and it is sometimes confused with a stroke since often the first symptoms of the condition are worsening headaches, nausea, vomiting, and seizures.

These dangerous brain tumors are infamous for being resistant to treatment and practically incurable. So often, the only way doctors can help a patient with glioblastoma is by reducing the disease's signs and symptoms. Thus, effective alternative treatments are urgently required, and the German research team led by Dr. Sjoerd van Wijk believes they have found one. According to a study published in the Autophagy journal at the end of October 2020, researchers started injecting loperamide into glioblastoma cells and found that it induces the cells' death.

Furthermore, the researchers also discovered why the drug is effective: introducing loperamide in the cell causes a stress response in the part of the cell called the endoplasmic reticulum (ER), an organelle that synthesizes the building blocks of cells - proteins. As a result, the cancer cells start to degrade and ultimately go into self-destruction mode. 

 

This specific mechanism of self-induced cancer cell death is known as autophagy-dependent cell death, from the Ancient Greek autóphagos meaning "self-devouring". To some extent, autophagy is a normal part of a cell’s life cycle that removes unnecessary or dysfunctional components from the cell. But when cancer cells were exposed to loperamide, it caused a process of self-degradation in the membrane of the ER and ultimately the entire cell. “Our experiments with cell lines show that autophagy could support the treatment of glioblastoma brain tumors,” stated van Wijk. 

 

Moreover, the researchers point out that the drug may be a feasible option for other difficult-to-treat neurological disorders or even dementia. At this point, the German research team is working on making a stronger customized version of loperamide that would be used specifically in the brain and ways to safely deliver the medication into the tumor without harming the healthy surrounding brain tissues. You see, simply taking the drug as you would normally to treat diarrhea would not help, as loperamide is actually not absorbed into the blood at all. 

 

Of course, we’ll keep you updated on any further developments of this new exciting treatment.

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement